Global and United States Gene Therapy for CNS Disorders Market Report & Forecast 2023-2028

Report ID: 1871806 | Published Date: Jan 2026 | No. of Page: 93 | Base Year: 2025 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Study Coverage
    1.1 Gene Therapy for CNS Disorders Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Gene Therapy for CNS Disorders Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Gene Therapy for CNS Disorders Market Size for the Year 2017-2028
        1.2.2 Global Gene Therapy for CNS Disorders Market Size for the Year 2017-2028
    1.3 Gene Therapy for CNS Disorders Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Gene Therapy for CNS Disorders in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Gene Therapy for CNS Disorders Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Gene Therapy for CNS Disorders Market Dynamics
        1.4.1 Gene Therapy for CNS Disorders Industry Trends
        1.4.2 Gene Therapy for CNS Disorders Market Drivers
        1.4.3 Gene Therapy for CNS Disorders Market Challenges
        1.4.4 Gene Therapy for CNS Disorders Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Gene Therapy for CNS Disorders by Type
    2.1 Gene Therapy for CNS Disorders Market Segment by Type
        2.1.1 Ex Vivo
        2.1.2 In Vivo
    2.2 Global Gene Therapy for CNS Disorders Market Size by Type (2017, 2022 & 2028)
    2.3 Global Gene Therapy for CNS Disorders Market Size by Type (2017-2028)
    2.4 United States Gene Therapy for CNS Disorders Market Size by Type (2017, 2022 & 2028)
    2.5 United States Gene Therapy for CNS Disorders Market Size by Type (2017-2028)
3 Gene Therapy for CNS Disorders by Application
    3.1 Gene Therapy for CNS Disorders Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Gene Therapy for CNS Disorders Market Size by Application (2017, 2022 & 2028)
    3.3 Global Gene Therapy for CNS Disorders Market Size by Application (2017-2028)
    3.4 United States Gene Therapy for CNS Disorders Market Size by Application (2017, 2022 & 2028)
    3.5 United States Gene Therapy for CNS Disorders Market Size by Application (2017-2028)
4 Global Gene Therapy for CNS Disorders Competitor Landscape by Company
    4.1 Global Gene Therapy for CNS Disorders Market Size by Company
        4.1.1 Top Global Gene Therapy for CNS Disorders Companies Ranked by Revenue (2021)
        4.1.2 Global Gene Therapy for CNS Disorders Revenue by Player (2017-2022)
    4.2 Global Gene Therapy for CNS Disorders Concentration Ratio (CR)
        4.2.1 Gene Therapy for CNS Disorders Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Therapy for CNS Disorders in 2021
        4.2.3 Global Gene Therapy for CNS Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Gene Therapy for CNS Disorders Headquarters, Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Gene Therapy for CNS Disorders Headquarters and Area Served
        4.3.2 Global Gene Therapy for CNS Disorders Companies Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Gene Therapy for CNS Disorders Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Gene Therapy for CNS Disorders Market Size by Company
        4.5.1 Top Gene Therapy for CNS Disorders Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Gene Therapy for CNS Disorders Revenue by Players (2020, 2021 & 2022)
5 Global Gene Therapy for CNS Disorders Market Size by Region
    5.1 Global Gene Therapy for CNS Disorders Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Gene Therapy for CNS Disorders Market Size by Region (2017-2028)
        5.2.1 Global Gene Therapy for CNS Disorders Market Size by Region: 2017-2022
        5.2.2 Global Gene Therapy for CNS Disorders Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Gene Therapy for CNS Disorders Market Size YoY Growth 2017-2028
        6.1.2 North America Gene Therapy for CNS Disorders Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Gene Therapy for CNS Disorders Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Gene Therapy for CNS Disorders Market Size YoY Growth 2017-2028
        6.3.2 Europe Gene Therapy for CNS Disorders Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Gene Therapy for CNS Disorders Market Size YoY Growth 2017-2028
        6.4.2 Latin America Gene Therapy for CNS Disorders Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Gene Therapy for CNS Disorders Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Gene Therapy for CNS Disorders Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Gilead (Kite Pharma)
        7.1.1 Gilead (Kite Pharma) Company Details
        7.1.2 Gilead (Kite Pharma) Business Overview
        7.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Introduction
        7.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        7.1.5 Gilead (Kite Pharma) Recent Development
    7.2 Amgen (BioVex)
        7.2.1 Amgen (BioVex) Company Details
        7.2.2 Amgen (BioVex) Business Overview
        7.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Introduction
        7.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        7.2.5 Amgen (BioVex) Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Details
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Gene Therapy for CNS Disorders Introduction
        7.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        7.3.5 Novartis Recent Development
    7.4 Roche (Spark Therapeutics)
        7.4.1 Roche (Spark Therapeutics) Company Details
        7.4.2 Roche (Spark Therapeutics) Business Overview
        7.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Introduction
        7.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        7.4.5 Roche (Spark Therapeutics) Recent Development
    7.5 Bluebird Bio
        7.5.1 Bluebird Bio Company Details
        7.5.2 Bluebird Bio Business Overview
        7.5.3 Bluebird Bio Gene Therapy for CNS Disorders Introduction
        7.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        7.5.5 Bluebird Bio Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Gene Therapy for CNS Disorders Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Gene Therapy for CNS Disorders Market Trends
    Table 3. Gene Therapy for CNS Disorders Market Drivers
    Table 4. Gene Therapy for CNS Disorders Market Challenges
    Table 5. Gene Therapy for CNS Disorders Market Restraints
    Table 6. Global Gene Therapy for CNS Disorders Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gene Therapy for CNS Disorders Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gene Therapy for CNS Disorders Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gene Therapy for CNS Disorders Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gene Therapy for CNS Disorders Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gene Therapy for CNS Disorders Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Gene Therapy for CNS Disorders Revenue Share by Player, 2017-2022
    Table 13. Global Gene Therapy for CNS Disorders Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Gene Therapy for CNS Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for CNS Disorders as of 2021)
    Table 15. Top Players of Gene Therapy for CNS Disorders in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Gene Therapy for CNS Disorders Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Gene Therapy for CNS Disorders Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Gene Therapy for CNS Disorders Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Gene Therapy for CNS Disorders Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Gene Therapy for CNS Disorders Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Gene Therapy for CNS Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Gene Therapy for CNS Disorders Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Gene Therapy for CNS Disorders Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Gene Therapy for CNS Disorders Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Gene Therapy for CNS Disorders Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Gene Therapy for CNS Disorders Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Gene Therapy for CNS Disorders Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Gilead (Kite Pharma) Company Details
    Table 31. Gilead (Kite Pharma) Business Overview
    Table 32. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product
    Table 33. Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 34. Gilead (Kite Pharma) Recent Development
    Table 35. Amgen (BioVex) Company Details
    Table 36. Amgen (BioVex) Business Overview
    Table 37. Amgen (BioVex) Gene Therapy for CNS Disorders Product
    Table 38. Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 39. Amgen (BioVex) Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Gene Therapy for CNS Disorders Product
    Table 43. Novartis Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Roche (Spark Therapeutics) Company Details
    Table 46. Roche (Spark Therapeutics) Business Overview
    Table 47. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product
    Table 48. Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 49. Roche (Spark Therapeutics) Recent Development
    Table 50. Bluebird Bio Company Details
    Table 51. Bluebird Bio Business Overview
    Table 52. Bluebird Bio Gene Therapy for CNS Disorders Product
    Table 53. Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 54. Bluebird Bio Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gene Therapy for CNS Disorders Product Picture
    Figure 2. Global Gene Therapy for CNS Disorders Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gene Therapy for CNS Disorders Market Size 2017-2028 (US$ Million)
    Figure 4. United States Gene Therapy for CNS Disorders Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Gene Therapy for CNS Disorders Market Size 2017-2028 (US$ Million)
    Figure 6. United States Gene Therapy for CNS Disorders Market Share in Global 2017-2028
    Figure 7. Gene Therapy for CNS Disorders Report Years Considered
    Figure 8. Product Picture of Ex Vivo
    Figure 9. Product Picture of In Vivo
    Figure 10. Global Gene Therapy for CNS Disorders Market Share by Type in 2022 & 2028
    Figure 11. Global Gene Therapy for CNS Disorders Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    Figure 13. United States Gene Therapy for CNS Disorders Market Share by Type in 2022 & 2028
    Figure 14. United States Gene Therapy for CNS Disorders Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Others
    Figure 19. Global Gene Therapy for CNS Disorders Market Share by Application in 2022 & 2028
    Figure 20. Global Gene Therapy for CNS Disorders Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    Figure 22. United States Gene Therapy for CNS Disorders Market Share by Application in 2022 & 2028
    Figure 23. United States Gene Therapy for CNS Disorders Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    Figure 25. North America Gene Therapy for CNS Disorders Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Gene Therapy for CNS Disorders Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Gene Therapy for CNS Disorders Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Gene Therapy for CNS Disorders Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Gene Therapy for CNS Disorders Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Gene Therapy for CNS Disorders Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Gilead (Kite Pharma) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 54. Amgen (BioVex) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 56. Roche (Spark Therapeutics) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 57. Bluebird Bio Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead (Kite Pharma)
Amgen (BioVex)
Novartis
Roche (Spark Therapeutics)
Bluebird Bio
Frequently Asked Questions
Gene Therapy for CNS Disorders report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapy for CNS Disorders report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapy for CNS Disorders report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Reels and Spools

Reels and Spools market is segmented by region (country), players, by Type and by Application. Pl ... Read More